Logo for 4SC AG

4SC Investor Relations Material

Latest events

Logo for 4SC AG

Q2 2024

4SC
Logo for 4SC

Q1 2025

17 Apr, 2025
Logo for 4SC

Q4 2024

28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from 4SC AG

Access all reports
4SC AG is a Germany-based biotechnology company focused on the development of small-molecule drugs for the treatment of cancer. The company’s research centers on epigenetic cancer therapies, particularly those aimed at modulating the immune system and tumor microenvironment. Its operations encompass drug discovery, clinical development, and regulatory activities. 4SC AG is headquartered in Planegg-Martinsried, Germany, and its shares are listed on the XETRA.